SEHK:6609Medical Equipment
Shanghai HeartCare Medical Technology (SEHK:6609) Profitability Turn Challenges Cautious Valuation Narratives
Shanghai HeartCare Medical Technology (SEHK:6609) has just posted its FY 2025 results, with first half revenue at C¥185.5 million and basic EPS of C¥1.34, while trailing twelve month revenue sits at C¥408.3 million and EPS at C¥2.21 as the business turned profitable over the past year. The company has seen revenue move from C¥128.5 million in the first half of 2024 to C¥149.4 million in the second half of 2024 and then to C¥185.5 million in the first half of 2025. This has come alongside a...